Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 5023973, 9 pages
http://dx.doi.org/10.1155/2016/5023973
Research Article

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis

1Department of Gastroenterology, Telemark Hospital, 3710 Skien, Norway
2Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, 0310 Oslo, Norway
3Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway
4Department of Gastroenterology, Oslo University Hospital, Ullevål, 0424 Oslo, Norway
5Department of Medicine, Gentofte Hospital, 2900 Hellerup, Denmark
6Ben-Gurion University of the Negev, 84105 Beersheba, Israel
7Department of Biostatistics, Oslo University Hospital, 0424 Oslo, Norway
8Department of Internal Medicine, University Hospital of Ferrara, 44124 Ferrara, Italy
9Department of Research and Development, Telemark Hospital, 3710 Skien, Norway

Received 30 March 2016; Accepted 11 July 2016

Academic Editor: Paolo Gionchetti

Copyright © 2016 Gert Huppertz-Hauss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Lennard-Jones, “Classification of inflammatory bowel disease,” Scandinavian Journal of Gastroenterology Supplement, vol. 170, pp. 2–19, 1989. View at Google Scholar
  2. S. Larsen, K. Bendtzen, and O. H. Nielsen, “Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management,” Annals of Medicine, vol. 42, no. 2, pp. 97–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. N. Bernstein, S. C. Ng, P. L. Lakatos, B. Moum, and E. V. Loftus Jr., “A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease,” Inflammatory Bowel Diseases, vol. 19, no. 9, pp. 2001–2010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. N. Bernstein, E. V. Loftus Jr., S. C. Ng, P. L. Lakatos, and B. Moum, “Hospitalisations and surgery in Crohn's disease,” Gut, vol. 61, no. 4, pp. 622–629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. P. L. Lakatos and L. Lakatos, “Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies,” World Journal of Gastroenterology, vol. 14, no. 25, pp. 3937–3947, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Rutgeerts, S. Vermeire, and G. Van Assche, “Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?” Gut, vol. 56, no. 4, pp. 453–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Odes, “How expensive is inflammatory bowel disease? A critical analysis,” World Journal of Gastroenterology, vol. 14, no. 43, pp. 6641–6647, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Odes, H. Vardi, M. Friger et al., “Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation,” Gastroenterology, vol. 131, no. 3, pp. 719–728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Drummond, M. J. Sculpher, G. W. Torrance, B. J. O'Brien, and G. L. Stoddard, Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, Oxford, UK, 2005.
  10. J. R. Brazier, J. A. Salomon, and A. Tsuchiya, Measuring and Valuing Health Benefits for Economic Evaluation, Oxford University Press, New York, NY, USA, 2007.
  11. G. Hawthorne and J. Richardson, “Measuring the value of program outcomes: a review of multiattribute utility measures,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 1, no. 2, pp. 215–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Quercioli, G. Messina, E. Barbini, G. Carriero, M. Fani, and N. Nante, “Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores,” The European Journal of Health Economics, vol. 10, no. 4, pp. 389–397, 2009. View at Google Scholar
  13. G. Hawthorne, J. Richardson, and N. A. Day, “A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments,” Annals of Medicine, vol. 33, no. 5, pp. 358–370, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Brazier, J. Roberts, A. Tsuchiya, and J. Busschbach, “A comparison of the EQ-5D and SF-6D across seven patient groups,” Health Economics, vol. 13, no. 9, pp. 873–884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. F. van Stel and E. Buskens, “Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease,” Health and Quality of Life Outcomes, vol. 4, article 20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. G. Johnsen, C. Hellum, Ø. P. Nygaard et al., “Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease,” BMC Musculoskeletal Disorders, vol. 14, article 148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bryan and L. Longworth, “Measuring health-related utility: why the disparity between EQ-5D and SF-6D?” The European Journal of Health Economics, vol. 6, no. 3, pp. 253–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Lillegraven, I. S. Kristiansen, and T. K. Kvien, “Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1762–1767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. H. Sach, G. R. Barton, C. Jenkinson, M. Doherty, A. J. Avery, and K. R. Muir, “Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?” Medical Care, vol. 47, no. 8, pp. 889–894, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Conner-Spady and M. E. Suarez-Almazor, “Variation in the estimation of quality-adjusted life-years by different preference-based instruments,” Medical Care, vol. 41, no. 7, pp. 791–801, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Marra, S. A. Marion, D. P. Guh et al., “Not all ‘quality-adjusted life years’ are equal,” Journal of Clinical Epidemiology, vol. 60, no. 6, pp. 616–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Longworth and S. Bryan, “An empirical comparison of EQ-5D and SF-6D in liver transplant patients,” Health Economics, vol. 12, no. 12, pp. 1061–1067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Bernklev, J. Jahnsen, E. Aadland et al., “Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis,” Scandinavian Journal of Gastroenterology, vol. 39, no. 4, pp. 365–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Hoivik, B. Moum, I. C. Solberg et al., “Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study,” Inflammatory Bowel Diseases, vol. 18, no. 8, pp. 1540–1549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. L. Høivik, T. Bernklev, I. C. Solberg et al., “Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study,” Journal of Crohn's & Colitis, vol. 6, no. 4, pp. 441–453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. W. Stockbrügger, M. G. V. M. Russel, M. van Blankenstein, and S. Shivananda, “EC-IBD: a European effort in inflammatory bowel disease,” European Journal of Internal Medicine, vol. 11, no. 4, pp. 187–190, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Brazier, T. Usherwood, R. Harper, and K. Thomas, “Deriving a preference-based single index from the UK SF-36 Health Survey,” Journal of Clinical Epidemiology, vol. 51, no. 11, pp. 1115–1128, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. F. L. Wolters, G. van Zeijl, J. Sijbrandij et al., “Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates,” World Journal of Gastroenterology, vol. 11, no. 45, pp. 7152–7158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Dolan, “Modeling valuations for EuroQol health states,” Medical Care, vol. 35, no. 11, pp. 1095–1108, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Brazier, J. Roberts, and M. Deverill, “The estimation of a preference-based measure of health from the SF-36,” Journal of Health Economics, vol. 21, no. 2, pp. 271–292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Kirkwood and J. Sterne, Essential Medical Statistics, Wiley-Blackwell, Malden, Mass, USA, 2nd edition, 2003.
  32. J. M. Bland and D. G. Altman, “Statistical methods for assessing agreement between two methods of clinical measurement,” The Lancet, vol. 1, no. 8476, pp. 307–310, 1986. View at Google Scholar · View at Scopus
  33. G. R. Norman, J. A. Sloan, and K. W. Wyrwich, “Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation,” Medical Care, vol. 41, no. 5, pp. 582–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. C. E. Metz, “Basic principles of ROC analysis,” Seminars in Nuclear Medicine, vol. 8, no. 4, pp. 283–298, 1978. View at Publisher · View at Google Scholar · View at Scopus
  35. G. R. Barton, T. H. Sach, A. J. Avery et al., “A comparison of the performance of the EQ-5D and SF-6D for individuals aged ≥ 45 years,” Health Economics, vol. 17, no. 7, pp. 815–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Huppertz-Hauss, M. Lie Høivik, E. Langholz et al., “Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis,” Inflammatory Bowel Diseases, vol. 21, no. 2, pp. 337–344, 2015. View at Publisher · View at Google Scholar · View at Scopus